Supplementary Figure S4: DPN induces growth inhibition and autophagy in L-540 xenografts in NOD/SCID mice.
A. NOD/SCID mice bearing 100-mm 3 L-540 tumor nodules were randomly assigned to receive 15-day treatment with DPN by intraperitoneal injection (3 mg/kg, 5 days/week for 3 weeks, blue; 6 mg/kg, 5 days/week for 3 weeks, green; 12 mg/kg, 5 days/week for 3 weeks, red) or vehicle control (black). Black arrows indicate DPN treatment administration whereas treatment duration is indicated by horizontal capped black lines (days 28-46). The mean (± SEM) tumor volumes are shown. *, p < 0.05 and **, p < 0.01 versus vehicle control. B. Ki-67 and C. LC3 and SQSTM1 staining of L-540 tumors treated with DPN (12 mg/kg/day, 5 days) or vehicle control. In the Ki-67-, LC3-, and SQSTM1-stained sections, brown staining represents a positive signal within the tumor. Objective lens, 0.75 numerical aperture (NA) dry objective; original magnification, 20x. Scale bar, 100 µm. D. In L-540 tumors treated with DPN (12 mg/kg/day, 5 days) or vehicle control, apoptotic tumor cells were detected by TUNEL staining and were revealed as brown nuclei using 3,3'-diaminobenzidine for light microscopy analysis. Objective lens, 0.08 NA dry objective; original magnification, 20x. Scale bar, 50 µm. E. Representative histological images of entire tumor sections from L-540 tumors treated with DPN (12 mg/kg/day, 5 days) or vehicle control. Tumor tissue morphology was detected via hematoxylin and eosin (H&E) staining. The tumor necrotic areas were detected via TUNEL staining and were visualized as brown. Objective lens, 0.08 NA dry objective; original magnification, 2x.
